Improved E. coli erythromycin a production through the application of metabolic and bioprocess engineering

Biotechnology Progress

Volumn 28, Issue 1, 2012, Pages 292-296

  Zhang, Haoran ^a   Skalina, Karin ^a   Jiang, Ming ^a   Pfeifer, Blaine A ^a  

^a Tufts University   (United States)

Author keywords

E. coli; Erythromycin A; Heterologous biosynthesis; Metabolic and process engineering

Indexed keywords

BATCH BIOREACTORS; BIOPROCESS ENGINEERING; BIOSYNTHETIC PATHWAY; CARBON FLOW; DEOXYSUGAR; E. COLI; ERYTHROMYCIN A; GLYCOSYL TRANSFERASE; HETEROLOGOUS PRODUCTION;

BIOCHEMISTRY; BIOREACTORS; BIOSYNTHESIS; ESCHERICHIA COLI; EXPERIMENTS; METABOLISM; STRAIN; SUGARS;

DRUG PRODUCTS;

ANTIINFECTIVE AGENT; ERYTHROMYCIN;

ARTICLE; BIOREACTOR; BIOSYNTHESIS; CULTURE MEDIUM; ESCHERICHIA COLI; FERMENTATION; METABOLISM; MICROBIOLOGY; PLASMID;

ANTI-BACTERIAL AGENTS; BIOREACTORS; BIOSYNTHETIC PATHWAYS; CULTURE MEDIA; ERYTHROMYCIN; ESCHERICHIA COLI; FERMENTATION; PLASMIDS;

ESCHERICHIA COLI;

EID: 84856576230     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.702     Document Type: Article

References (25)

1. Berdy J. Bioactive microbial metabolites. J Antibiot (Tokyo). 2005; 58: 1-26.
2. Clardy J, Fischbach MA, Walsh CT. New antibiotics from bacterial natural products. Nat Biotechnol. 2006; 24: 1541-1550.
3. Demain AL. From natural products discovery to commercialization: a success story. J Ind Microbiol Biotechnol. 2006; 33: 486-495.
4. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005; 4: 206-220.
5. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007; 70: 461-477.
6. Zhang H, Boghigian BA, Armando J, Pfeifer BA. Methods and options for the heterologous production of complex natural products. Nat Prod Rep. 17 2011; 28: 125-151.
7. McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, Smith JW. "Ilotycin, " a new antibiotic. Antibiot Chemother. 1952; 2: 281-284.
8. Haight TH, Finland M. The antibacterial action of erythromycin. Proc Soc Exp Biol Med. 1952; 81: 175-183.
9. Brunker P, Minas W, Kallio PT, Bailey JE. Genetic engineering of an industrial strain of Saccharopolyspora erythraea for stable expression of the Vitreoscilla haemoglobin gene (vhb). Microbiology. 1998; 144 ( Part 9): 2441-2448.
10. Wang Y, Chu J, Zhuang Y, Zhang L, Zhang S. Improved production of erythromycin A by expression of a heterologous gene encoding S-adenosylmethionine synthetase. Appl Microbiol Biotechnol. 2007; 75: 837-842.
11. Zhang S, Chu J, Zhuang Y. A multi-scale study of industrial fermentation processes and their optimization. Adv Biochem Eng Biotechnol. 2004; 87: 97-150.
12. Rodriguez E, Hu Z, Ou S, Volchegursky Y, Hutchinson CR, McDaniel R. Rapid engineering of polyketide overproduction by gene transfer to industrially optimized strains. J Ind Microbiol Biotechnol. 2003; 30: 480-488.
13. Minas W, Brunker P, Kallio PT, Bailey JE. Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol Prog. 1998; 14: 561-566.
14. Chen Y, Deng W, Wu J, Qian J, Chu J, Zhuang Y, Zhang S, Liu W. Genetic modulation of the overexpression of tailoring genes eryK and eryG leading to the improvement of erythromycin A purity and production in Saccharopolyspora erythraea fermentation. Appl Environ Microbiol. 2008; 74: 1820-1828.
15. Zou X, Hang HF, Chu J, Zhuang YP, Zhang SL. Enhancement of erythromycin A production with feeding available nitrogen sources in erythromycin biosynthesis phase. Bioresour Technol. 2009; 100: 3358-3365.
16. Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science. 2001; 291: 1790-1792.
17. Peiru S, Menzella HG, Rodriguez E, Carney J, Gramajo H. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl Environ Microbiol. 2005; 71: 2539-2547.
18. Lee HY, Khosla C. Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLoS Biol. 2007; 5: e45.
19. Zhang H, Wang Y, Wu J, Skalina K, Pfeifer BA. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem Biol. 2010; 17: 1232-1240.
20. Zhang H, Boghigian BA, Pfeifer BA. Investigating the role of native propionyl-CoA and methylmalonyl-CoA metabolism on heterologous polyketide production in Escherichia coli. Biotechnol Bioeng. 2010; 105: 567-573.
21. Haller T, Buckel T, Retey J, Gerlt JA. Discovering new enzymes and metabolic pathways: conversion of succinate to propionate by Escherichia coli. Biochemistry. 2000; 39: 4622-4629.
22. Summers RG, Donadio S, Staver MJ, Wendt-Pienkowski E, Hutchinson CR, Katz L. Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production. Microbiology. 1997; 143 ( Part 10): 3251-3262.
23. Peiru SR, Rodriguez E, Menzella HG, Carney JR, Gramajo H. Metabolically engineered Escherichia coli for efficient production of glycosylated natural products. Microb Biotechnol. 2008; 1: 476-486.
24. Menzella HG, Reisinger SJ, Welch M, Kealey JT, Kennedy J, Reid R, Tran CQ, Santi DV. Redesign, synthesis and functional expression of the 6-deoxyerythronolide B polyketide synthase gene cluster. J Ind Microbiol Biotechnol. 2006; 33: 22-28.
25. 3 scale. Bioresour Technol. 2009; 100: 1406-1412.